Ultimately, it should be noted that the use of TIMP-2*IGFBP-7 has been approved primarily for the early detection of AKI, and its use for predicting RRT so far remains an off-label application but is subject of investigations [21]. The gene discussed is TIMP2; the disease is acute kidney injury.